185 related articles for article (PubMed ID: 7045566)
1. [Therapeutic effect of etofyllinclofibrate in disordered lipid and uric acid metabolism].
Fiegel G
Med Welt; 1982 Mar; 33(9):334-6. PubMed ID: 7045566
[No Abstract] [Full Text] [Related]
2. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
Machalke K; Djaja S; Richter E
Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
[No Abstract] [Full Text] [Related]
3. [Basic principles of drug therapy of hyperlipoproteinemia].
Romics L
Orv Hetil; 1988 Nov; 129(45):2391-9. PubMed ID: 3054710
[No Abstract] [Full Text] [Related]
4. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
Słowińska R; Bochenek W; Unlot J
Pol Tyg Lek; 1983 Apr; 38(17):529-32. PubMed ID: 6356087
[No Abstract] [Full Text] [Related]
5. [Etofibrate in severe diet-refractory cases of hyperlipoproteinemia].
Schatton W; Holm E
Fortschr Med; 1986 Apr; 104(13):280-2. PubMed ID: 3699655
[No Abstract] [Full Text] [Related]
6. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
Ceska R; Sobra J; Procházková R; Kvasilová M
Vnitr Lek; 1990 Apr; 36(4):363-7. PubMed ID: 2356612
[TBL] [Abstract][Full Text] [Related]
7. [Atherosclerosis treatment with etofibrate retard. New perspectives].
Degenring FH; Schatton W; Hotz W
Fortschr Med; 1983 Aug; 101(30):1391-6. PubMed ID: 6618402
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
9. [Duolip Forte--experience during a 6-month period of administration].
Toschnerová H; Ceska R; Sobra J; Traurig J
Cas Lek Cesk; 1993 May; 132(10):308-10. PubMed ID: 8513467
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology and mechanism of action of etofibrate].
Schatton W
Med Welt; 1982 Sep; 33(38):1310-4. PubMed ID: 6752630
[No Abstract] [Full Text] [Related]
11. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
12. [Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)].
Jarillo MD; Coca MC; Díaz Rubio C; Bello I; Gutiérrez-Millet V; Ruilope LM; Rodicio JL; Alvarez Ude F
Med Clin (Barc); 1980 Nov; 75(8):334-7. PubMed ID: 7442334
[TBL] [Abstract][Full Text] [Related]
13. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
14. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
15. [Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
Scherhag R
Fortschr Med; 1983 Sep; 101(36):1635-7. PubMed ID: 6629296
[TBL] [Abstract][Full Text] [Related]
16. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
[No Abstract] [Full Text] [Related]
17. [Therapy with fibrates and vitamin D metabolism].
Wilczek H; Sobra J; Ceska R; Justová V; Procházková R; Kvasilová M; Jůzová Z
Cas Lek Cesk; 1993 Oct; 132(20):630-2. PubMed ID: 8269466
[TBL] [Abstract][Full Text] [Related]
18. [On the uricosuric activity of etofylline clofibrate (author's transl)].
Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2073-4. PubMed ID: 7194063
[TBL] [Abstract][Full Text] [Related]
19. Hypolipemic profile of plafibride in a model of experimental atherosclerosis.
Badimón JJ; Padró T; Cánovas M; Vidal M; Villaverde CA
Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):613-7. PubMed ID: 6668971
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of the therapeutic activity of the beta-pyridyl-carbinolic ester of clofibric acid].
Silingardi V; Renzi R; Mora A; Di Prisco AU
Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4579325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
